出版：MarketsandMarkets（マーケッツアンドマーケッツ） 出版年月：2023年11月
Nucleic Acid Isolation and Purification Market – Global Forecast to 2028
核酸分離・精製市場 : 製品（キット、試薬、機器）、メソッド（カラム、磁気ビーズ）、タイプ（ゲノムDNA、プラスミドDNA、mRNA）、用途（診断、個別化医療）、エンドユーザー（CRO）、地域別 – 2028年までの世界予測
Nucleic Acid Isolation and Purification Market by Product (Kits, Reagents, Instruments), Method (Column, Magnetic Beads), Type (Genomic DNA, Plasmid DNA, mRNA), Application (Diagnostics, Personalized Medicine), End User (CROs) & Region – Global Forecast to 2028
| ページ数 | 373 |
| 図表数 | 406 |
| 種別 | 英文調査報告書 |
| 価格 |
Report Overview
The global Nucleic acid isolation and purification market is projected to reach USD 9.4 billion by 2028 from USD 6.4 billion in 2023, at a CAGR of 8.1% during the forecast period. The factors responsible for the growth of this market include increasing automation, growing research and development activities and increasing technological advancements.
In 2022, the kits segment accounted for the largest share of the global nucleic acid isolation and purification market.
Based on products, the nucleic acid isolation and purification market has been segmented into kits, reagents, and instruments. The instruments segment is further segmented into automatic and manual instruments. In 2022, the kits segment accounted for the largest share of the global nucleic acid isolation and purification market. Factors responsible for the growth in this market include easy usage and cost of kits in applications including molecular diagnostics, gene sequencing, and gene cloning, and the continuous focus of key market players on developing and launching advanced kits.
In 2022, the plasmid DNA isolation segment accounted for the largest share of the market.
Based on type, the global nucleic acid isolation and purification market is segmented into plasmid DNA, total RNA, circulating nucleic acid, genomic DNA, messenger RNA, microRNA, and other nucleic acid isolation and purification types. In 2022, the plasmid DNA isolation and purification segment dominated the global nucleic acid isolation and purification market. The growth of this segment can be attributed to several factors. Firstly, the market benefits from the wide availability of diverse extraction and processing kits specifically designed for plasmid DNA. Additionally, the increasing utilization of plasmid DNA in gene expression profiling and its widespread application in various downstream processes contribute to the segment’s expansion.
In 2022, the diagnostics segment accounted for the largest share of the global nucleic acid isolation and purification market.
Based on application, the global nucleic acid isolation and purification market is segmented into personalized medicine, diagnostics, agriculture & animal research, drug discovery & development, and other applications. The diagnostics segment dominated the global nucleic acid isolation and purification market in 2022. Several factors contributed to the segment’s prominence including the growing utilization of DNA and RNA isolation in routine sample processing for pathogen identification, the increasing awareness of genomic diagnostics among patients and the improved efficiency of genomics sequencing in disease diagnosis.
In 2022, North America accounted for the largest share of the nucleic acid isolation and purification market.
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In 2022, North America dominated the global nucleic acid isolation and purification market. The dominance of the regon can be attributed to factors such as presence of key players in the region, increasing R&D spending in pharmaceutical and biotechnology companies, government support, and technological advancements, in the region.
The primary interviews conducted for this report can be categorized as follows:
• By Respondent: Supply Side- 80% and Demand Side 20%
• By Designation: Managers- 45%, CXOs and Directors – 30%, and Executives – 25%
• By Region: North America -37%, Europe -30%, Asia-Pacific -25%, Latin America -5%, Middle East & Africa- 3%
List of Companies Profiled in the Report:
• Thermo Fisher Scientific Inc. (US)
• Merck KGaA (Germany)
• QIAGEN (Germany)
• F. Hoffmann-La Roche Ltd. (Switzerland)
• Promega Corporation (US)
• Agilent Technologies, Inc. (US)
• Danaher(US)
• Bio-Rad Laboratories, Inc. (US)
• Illumina, Inc. (US)
• Takara Bio Inc. (Japan)
• New England Biolabs (US)
• Abcam Plc (UK)
• KILPEST India Limited (India)
• Apical Scientific Sdn. Bhd. (Malaysia)
• Endress+Hauser Group Services AG (Switzerland)
• GENAXXON bioscience GmbH (Germany)
• LGC Biosearch Technologies (US)
• Zymo Research Corporation (US)
• Norgen Biotek Corp. (Canada)
• Omega Bio-Tek, Inc. (US)
• FAVORGEN Biotech Corp. (China)
• TIANGEN Biotech (Beijing) Co., Ltd. (China)
• AutoGen Inc. (US)
• PCR Biosystems (UK)
• Biogenuix (India)
Research Coverage: The report comprehensively encompasses in-depth information about the significant factors that impact the growth of the NAIP market, including drivers, restraints, challenges, and opportunities. A meticulous analysis of the leading industry players has been conducted to offer insights into their business overview, solutions, and products. Additionally, the report examines their key strategies, such as partnerships, agreements, new product launches, mergers and acquisitions, and recent developments associated with the NAIP market. Furthermore, the report covers a competitive analysis of emerging startups in the NAIP market ecosystem.
Reasons to Buy the Report
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall NAIP market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
• Analysis of key drivers (Increasing R&D activities, Technological advancements and increasing automation, Growing demand for molecular diagnostics), restraints (High cost of automated instruments), opportunities (Growth opportunities in emerging economies, Improving regulatory and reimbursement scenario, Molecular diagnostics and personalized medicine), and challenges (Operational barriers and shortage of skilled professionals, and Introduction of alternative technologies) influencing the growth of the nucleic acid isolation and purification market.
• Product Development/Innovation: Detailed insights on upcoming trends, research & development activities, and new product launches in the nucleic acid isolation and purification market.
• Market Development: Comprehensive information about lucrative markets – the report analyses the nucleic acid isolation and purification market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Nucleic acid isolation and purification market
• Competitive Assessment: In-depth assessment of market shares, growth strategies and product offerings of leading players like Thermo Fisher Scientific Inc. (US), QIAGEN (Germany), Merck KGaA (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Promega Corporation (US), Agilent Technologies, Inc. (US), Danaher(US), Bio-Rad Laboratories, Inc. (US), Illumina, Inc. (US), Takara Bio Inc. (Japan), New England Biolabs (US), Abcam Plc (UK), KILPEST India Limited (India), Apical Scientific Sdn. Bhd. (Malaysia), Endress+Hauser Group Services AG (Switzerland), GENAXXON bioscience GmbH (Germany), LGC Biosearch Technologies (US), Zymo Research Corporation (US), Norgen Biotek Corp. (Canada), Omega Bio-Tek, Inc. (US), FAVORGEN Biotech Corp. (China), TIANGEN Biotech (Beijing) Co., Ltd. (China), AutoGen Inc. (US), PCR Biosystems (UK), and Biogenuix (India).
Table of Contents
1 INTRODUCTION 44
1.1 STUDY OBJECTIVES 44
1.2 MARKET DEFINITION 44
1.2.1 INCLUSIONS & EXCLUSIONS 45
1.3 STUDY SCOPE 46
1.3.1 MARKETS COVERED 46
1.3.2 YEARS CONSIDERED 47
1.4 CURRENCY 47
1.5 LIMITATIONS 47
1.6 STAKEHOLDERS 48
1.7 SUMMARY OF CHANGES 48
1.8 RECESSION IMPACT 49
2 RESEARCH METHODOLOGY 50
2.1 RESEARCH DATA 50
FIGURE 1 RESEARCH DESIGN 50
2.1.1 SECONDARY DATA 51
2.1.2 PRIMARY DATA 52
FIGURE 2 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BREAKDOWN OF PRIMARIES 52
2.2 MARKET SIZE ESTIMATION 53
FIGURE 3 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: MARKET SIZE ESTIMATION FOR SUPPLY-SIDE ANALYSIS (2022) 53
FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS) FOR 2022 54
FIGURE 5 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE ANALYSIS FOR 2022 54
2.2.1 PRIMARY INSIGHTS 56
FIGURE 6 MARKET VALIDATION FROM PRIMARY EXPERTS 56
FIGURE 7 TOP-DOWN APPROACH 56
2.3 MARKET GROWTH RATE PROJECTIONS 57
FIGURE 8 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: CAGR PROJECTIONS FOR FORECAST PERIOD 58
FIGURE 9 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, CHALLENGES, AND OPPORTUNITIES 58
2.4 DATA TRIANGULATION APPROACH 59
FIGURE 10 DATA TRIANGULATION METHODOLOGY 59
2.5 STUDY ASSUMPTIONS 60
2.6 RISK ANALYSIS 60
2.7 RECESSION IMPACT ANALYSIS 60
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2028 (% GROWTH) 60
TABLE 2 US HEALTH EXPENDITURE, 2019–2022 (USD MILLION) 61
TABLE 3 US HEALTH EXPENDITURE, 2023–2028 (USD MILLION) 62
3 EXECUTIVE SUMMARY 63
FIGURE 11 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION) 63
FIGURE 12 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2023 VS. 2028 (USD MILLION) 64
FIGURE 13 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 65
FIGURE 14 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION) 65
FIGURE 15 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 66
FIGURE 16 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: GEOGRAPHIC SNAPSHOT 67
4 PREMIUM INSIGHTS 68
4.1 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET OVERVIEW 68
FIGURE 17 TECHNOLOGICAL ADVANCEMENTS AND INCREASED AUTOMATION TO DRIVE MARKET GROWTH 68
4.2 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT AND COUNTRY 69
FIGURE 18 KITS DOMINATED NORTH AMERICAN NUCLEIC ACID ISOLATION AND PURIFICATION PRODUCTS MARKET IN 2023 69
4.3 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET SHARE, BY TYPE, 2022 69
FIGURE 19 PLASMID DNA ISOLATION AND PURIFICATION SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2022 69
4.4 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET SHARE, BY PRODUCT, 2022 70
FIGURE 20 KITS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2022 70
4.5 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET SHARE, BY METHOD, 2022 70
FIGURE 21 MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION SEGMENT ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2022 70
4.6 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET SHARE, BY APPLICATION, 2022 71
FIGURE 22 DIAGNOSTICS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2022 71
4.7 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET SHARE, BY END USER, 2022 71
FIGURE 23 HOSPITALS & DIAGNOSTIC CENTERS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2022 71
4.8 GEOGRAPHICAL SNAPSHOT OF NUCLEIC ACID ISOLATION AND PURIFICATION MARKET 72
FIGURE 24 CHINA TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD 72
5 MARKET OVERVIEW 73
5.1 INTRODUCTION 73
5.2 MARKET DYNAMICS 73
FIGURE 25 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 73
TABLE 4 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 74
5.2.1 DRIVERS 74
5.2.1.1 Increasing R&D activities 74
5.2.1.2 Technological advancements and increasing automation 76
5.2.1.3 Growing demand for molecular diagnostics 76
TABLE 5 ESTIMATED NUMBER OF NEW CANCER CASES GLOBALLY, BY TYPE OF CANCER, 2020 VS. 2025 77
TABLE 6 GLOBAL CANCER INCIDENCE, BY REGION, 2020 VS. 2025 77
5.2.2 RESTRAINTS 78
5.2.2.1 High cost of automated instruments 78
5.2.3 OPPORTUNITIES 79
5.2.3.1 Growth opportunities in emerging economies 79
5.2.3.2 Improving regulatory and reimbursement scenario 80
5.2.3.3 Molecular diagnostics and personalized medicine 81
5.2.4 CHALLENGES 81
5.2.4.1 Operational barriers and shortage of skilled professionals 81
5.2.4.2 Introduction of alternative technologies 82
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 82
FIGURE 26 REVENUE SHIFT & NEW REVENUE POCKETS FOR NUCLEIC ACID ISOLATION AND PURIFICATION MARKET PROVIDERS 82
5.4 PATENT ANALYSIS 83
FIGURE 27 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: PATENT APPLICATIONS, OCTOBER 2013–OCTOBER 2023 83
TABLE 7 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: INDICATIVE LIST OF PATENTS 83
5.5 VALUE CHAIN ANALYSIS 84
FIGURE 28 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: VALUE CHAIN ANALYSIS 84
5.6 SUPPLY CHAIN ANALYSIS 85
FIGURE 29 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: SUPPLY CHAIN ANALYSIS 86
5.7 ECOSYSTEM ANALYSIS 86
TABLE 8 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: ECOSYSTEM ANALYSIS 87
5.8 KEY CONFERENCES & EVENTS IN 2023–2024 88
TABLE 9 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: DETAILED LIST OF CONFERENCES & EVENTS IN 2023–2024 88
5.9 PRICING ANALYSIS 89
5.9.1 AVERAGE SELLING PRICE, BY PRODUCT 89
TABLE 10 AVERAGE SELLING PRICE OF NUCLEIC ACID ISOLATION AND PURIFICATION PRODUCTS, 2022–2023 (USD) 89
5.9.2 AVERAGE SELLING PRICE, BY REGION 90
TABLE 11 AVERAGE SELLING PRICE OF NUCLEIC ACID ISOLATION AND PURIFICATION PRODUCTS, BY REGION, 2022–2023 (USD) 90
5.10 TECHNOLOGY ANALYSIS 90
5.11 PORTER’S FIVE FORCES ANALYSIS 91
TABLE 12 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: PORTER’S FIVE FORCES ANALYSIS 91
5.11.1 THREAT OF NEW ENTRANTS 92
5.11.2 THREAT OF SUBSTITUTES 92
5.11.3 BARGAINING POWER OF SUPPLIERS 92
5.11.4 BARGAINING POWER OF BUYERS 92
5.11.5 INTENSITY OF COMPETITIVE RIVALRY 92
5.12 REGULATORY ANALYSIS 93
5.12.1 REGULATORY BODIES 94
TABLE 13 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 94
TABLE 14 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 94
TABLE 15 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 95
TABLE 16 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 95
TABLE 17 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 95
5.13 KEY STAKEHOLDERS & BUYING CRITERIA 96
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS 96
FIGURE 30 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF NUCLEIC ACID ISOLATION AND PURIFICATION PRODUCTS 96
5.13.2 BUYING CRITERIA FOR NUCLEIC ACID ISOLATION AND PURIFICATION PRODUCTS 97
FIGURE 31 KEY BUYING CRITERIA FOR END USERS 97
6 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT 98
6.1 INTRODUCTION 99
TABLE 18 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 99
6.2 KITS 99
6.2.1 KITS TO ACCOUNT FOR LARGEST SHARE OF MARKET DURING FORECAST PERIOD 99
TABLE 19 NUCLEIC ACID ISOLATION AND PURIFICATION KITS MARKET, BY REGION, 2021–2028 (USD MILLION) 100
TABLE 20 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION KITS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 101
TABLE 21 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION KITS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 101
TABLE 22 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION KITS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 102
TABLE 23 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION KITS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 102
TABLE 24 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION KITS MARKET, BY REGION, 2021–2028 (USD MILLION) 102
6.3 REAGENTS 103
6.3.1 AVAILABILITY OF READY-TO-USE REAGENTS TO DRIVE GROWTH 103
TABLE 25 NUCLEIC ACID ISOLATION AND PURIFICATION REAGENTS MARKET, BY REGION, 2021–2028 (USD MILLION) 104
TABLE 26 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 104
TABLE 27 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 105
TABLE 28 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 105
TABLE 29 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 106
TABLE 30 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION REAGENTS MARKET, BY REGION, 2021–2028 (USD MILLION) 106
6.4 INSTRUMENTS 106
TABLE 31 NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 107
TABLE 32 NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY REGION, 2021–2028 (USD MILLION) 108
TABLE 33 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 108
TABLE 34 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 109
TABLE 35 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 109
TABLE 36 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 110
TABLE 37 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY REGION, 2021–2028 (USD MILLION) 110
6.4.1 AUTOMATIC INSTRUMENTS 110
6.4.1.1 Benefits of automatic instruments to drive growth 110
TABLE 38 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AUTOMATIC INSTRUMENTS, BY REGION, 2021–2028 (USD MILLION) 111
TABLE 39 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AUTOMATIC INSTRUMENTS, BY COUNTRY, 2021–2028 (USD MILLION) 111
TABLE 40 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AUTOMATIC INSTRUMENTS, BY COUNTRY, 2021–2028 (USD MILLION) 112
TABLE 41 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AUTOMATIC INSTRUMENTS, BY COUNTRY, 2021–2028 (USD MILLION) 112
TABLE 42 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AUTOMATIC INSTRUMENTS, BY COUNTRY, 2021–2028 (USD MILLION) 113
TABLE 43 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AUTOMATIC INSTRUMENTS, BY REGION, 2021–2028 (USD MILLION) 113
6.4.2 MANUAL INSTRUMENTS 113
6.4.2.1 Growing demand for nucleic acid isolation and purification in research and clinical applications to drive growth 113
TABLE 44 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR MANUAL INSTRUMENTS, BY REGION, 2021–2028 (USD MILLION) 114
TABLE 45 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR MANUAL INSTRUMENTS, BY COUNTRY, 2021–2028 (USD MILLION) 114
TABLE 46 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR MANUAL INSTRUMENTS, BY COUNTRY, 2021–2028 (USD MILLION) 115
TABLE 47 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR MANUAL INSTRUMENTS, BY COUNTRY, 2021–2028 (USD MILLION) 115
TABLE 48 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR MANUAL INSTRUMENTS, BY COUNTRY, 2021–2028 (USD MILLION) 116
TABLE 49 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR MANUAL INSTRUMENTS, BY REGION, 2021–2028 (USD MILLION) 116
7 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD 117
7.1 INTRODUCTION 118
TABLE 50 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021–2028 (USD MILLION) 118
7.2 MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION 118
7.2.1 MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION SEGMENT TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 118
TABLE 51 MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION MARKET, BY REGION, 2021–2028 (USD MILLION) 119
TABLE 52 NORTH AMERICA: MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 119
TABLE 53 EUROPE: MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 120
TABLE 54 ASIA PACIFIC: MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 120
TABLE 55 LATIN AMERICA: MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 121
TABLE 56 MIDDLE EAST & AFRICA: MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION MARKET, BY REGION, 2021–2028 (USD MILLION) 121
7.3 REAGENT-BASED ISOLATION AND PURIFICATION 121
7.3.1 REAGENT-BASED ISOLATION AND PURIFICATION SEGMENT TO REGISTER STEADY GROWTH DURING FORECAST PERIOD 121
TABLE 57 REAGENT-BASED ISOLATION AND PURIFICATION MARKET, BY REGION, 2021–2028 (USD MILLION) 122
TABLE 58 NORTH AMERICA: REAGENT-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 122
TABLE 59 EUROPE: REAGENT-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 123
TABLE 60 ASIA PACIFIC: REAGENT-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 123
TABLE 61 LATIN AMERICA: REAGENT-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 124
TABLE 62 MIDDLE EAST & AFRICA: REAGENT-BASED ISOLATION AND PURIFICATION MARKET, BY REGION, 2021–2028 (USD MILLION) 124
7.4 COLUMN-BASED ISOLATION AND PURIFICATION 124
7.4.1 GROWING POPULARITY OF COLUMN-BASED ISOLATION AND PURIFICATION IN CURRENT KITS TO BOOST MARKET 124
TABLE 63 COLUMN-BASED ISOLATION AND PURIFICATION MARKET, BY REGION, 2021–2028 (USD MILLION) 125
TABLE 64 NORTH AMERICA: COLUMN-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 125
TABLE 65 EUROPE: COLUMN-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 126
TABLE 66 ASIA PACIFIC: COLUMN-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 126
TABLE 67 LATIN AMERICA: COLUMN-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 127
TABLE 68 MIDDLE EAST & AFRICA: COLUMN-BASED ISOLATION AND PURIFICATION MARKET, BY REGION, 2021–2028 (USD MILLION) 127
7.5 OTHER ISOLATION AND PURIFICATION METHODS 127
TABLE 69 OTHER ISOLATION AND PURIFICATION METHODS MARKET, BY REGION, 2021–2028 (USD MILLION) 128
TABLE 70 NORTH AMERICA: OTHER ISOLATION AND PURIFICATION METHODS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 128
TABLE 71 EUROPE: OTHER ISOLATION AND PURIFICATION METHODS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 129
TABLE 72 ASIA PACIFIC: OTHER ISOLATION AND PURIFICATION METHODS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 129
TABLE 73 LATIN AMERICA: OTHER ISOLATION AND PURIFICATION METHODS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 130
TABLE 74 MIDDLE EAST & AFRICA: OTHER ISOLATION AND PURIFICATION METHODS MARKET, BY REGION, 2021–2028 (USD MILLION) 130
8 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE 131
8.1 INTRODUCTION 132
TABLE 75 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 132
8.2 PLASMID DNA ISOLATION AND PURIFICATION 132
8.2.1 PLASMID DNA ISOLATION AND PURIFICATION TO ACCOUNT FOR LARGEST SHARE OF MARKET 132
TABLE 76 PLASMID DNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2021–2028 (USD MILLION) 133
TABLE 77 NORTH AMERICA: PLASMID DNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 134
TABLE 78 EUROPE: PLASMID DNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 134
TABLE 79 ASIA PACIFIC: PLASMID DNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 135
TABLE 80 LATIN AMERICA: PLASMID DNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 135
TABLE 81 MIDDLE EAST & AFRICA: PLASMID DNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2021–2028 (USD MILLION) 135
8.3 TOTAL RNA ISOLATION AND PURIFICATION 136
8.3.1 WIDE USE OF TOTAL RNA ISOLATION AND PURIFICATION FOR RESEARCH AND DIAGNOSTIC APPLICATIONS TO BOOST MARKET 136
TABLE 82 TOTAL RNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2021–2028 (USD MILLION) 136
TABLE 83 NORTH AMERICA: TOTAL RNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 137
TABLE 84 EUROPE: TOTAL RNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 137
TABLE 85 ASIA PACIFIC: TOTAL RNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 138
TABLE 86 LATIN AMERICA: TOTAL RNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 138
TABLE 87 MIDDLE EAST & AFRICA: TOTAL RNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2021–2028 (USD MILLION) 138
8.4 GENOMIC DNA ISOLATION AND PURIFICATION 139
8.4.1 IMPORTANCE OF GENOMIC DNA ISOLATION IN GENETIC-BASED TESTS TO SUPPORT GROWTH 139
TABLE 88 GENOMIC DNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2021–2028 (USD MILLION) 139
TABLE 89 NORTH AMERICA: GENOMIC DNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 140
TABLE 90 EUROPE: GENOMIC DNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 140
TABLE 91 ASIA PACIFIC: GENOMIC DNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 141
TABLE 92 LATIN AMERICA: GENOMIC DNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 141
TABLE 93 MIDDLE EAST & AFRICA: GENOMIC DNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2021–2028 (USD MILLION) 141
8.5 MESSENGER RNA ISOLATION AND PURIFICATION 142
8.5.1 ROLE PLAYED BY MESSENGER RNA ISOLATION AND PURIFICATION IN GENE EXPRESSION AND TRANSCRIPTOMICS TO DRIVE GROWTH 142
TABLE 94 MESSENGER RNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2021–2028 (USD MILLION) 142
TABLE 95 NORTH AMERICA: MESSENGER RNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 143
TABLE 96 EUROPE: MESSENGER RNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 143
TABLE 97 ASIA PACIFIC: MESSENGER RNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 144
TABLE 98 LATIN AMERICA: MESSENGER RNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 144
TABLE 99 MIDDLE EAST & AFRICA: MESSENGER RNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2021–2028 (USD MILLION) 144
8.6 CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION 145
8.6.1 ABILITY OF CIRCULATING NAIP TO ENABLE COLLECTION OF GENETIC INFORMATION FROM BODY FLUIDS TO BOOST ADOPTION 145
TABLE 100 CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2021–2028 (USD MILLION) 145
TABLE 101 NORTH AMERICA: CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 146
TABLE 102 EUROPE: CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 146
TABLE 103 ASIA PACIFIC: CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 147
TABLE 104 LATIN AMERICA: CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 147
TABLE 105 MIDDLE EAST & AFRICA: CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2021–2028 (USD MILLION) 147
8.7 MICRORNA ISOLATION AND PURIFICATION 148
8.7.1 GROWING APPLICATIONS OF MICRORNA ISOLATION AND PURIFICATION IN DRUG DEVELOPMENT RESEARCH TO FUEL GROWTH 148
TABLE 106 MICRORNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2021–2028 (USD MILLION) 148
TABLE 107 NORTH AMERICA: MICRORNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 149
TABLE 108 EUROPE: MICRORNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 149
TABLE 109 ASIA PACIFIC: MICRORNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 150
TABLE 110 LATIN AMERICA: MICRORNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 150
TABLE 111 MIDDLE EAST & AFRICA: MICRORNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2021–2028 (USD MILLION) 150
8.8 OTHER NUCLEIC ACID ISOLATION AND PURIFICATION TYPES 151
TABLE 112 OTHER NUCLEIC ACID ISOLATION AND PURIFICATION TYPES MARKET, BY REGION, 2021–2028 (USD MILLION) 151
TABLE 113 NORTH AMERICA: OTHER NUCLEIC ACID ISOLATION AND PURIFICATION TYPES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 151
TABLE 114 EUROPE: OTHER NUCLEIC ACID ISOLATION AND PURIFICATION TYPES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 152
TABLE 115 ASIA PACIFIC: OTHER NUCLEIC ACID ISOLATION AND PURIFICATION TYPES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 152
TABLE 116 LATIN AMERICA: OTHER NUCLEIC ACID ISOLATION AND PURIFICATION TYPES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 153
TABLE 117 MIDDLE EAST & AFRICA: OTHER NUCLEIC ACID ISOLATION AND PURIFICATION TYPES MARKET, BY REGION, 2021–2028 (USD MILLION) 153
9 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION 154
9.1 INTRODUCTION 155
TABLE 118 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 155
9.2 DIAGNOSTICS 155
9.2.1 DIAGNOSTIC APPLICATIONS TO DOMINATE MARKET DURING FORECAST PERIOD 155
TABLE 119 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 156
TABLE 120 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 156
TABLE 121 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 157
TABLE 122 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 157
TABLE 123 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 158
TABLE 124 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 158
9.3 DRUG DISCOVERY & DEVELOPMENT 158
9.3.1 POTENTIAL OF NAIP TO HELP IN DEVELOPMENT OF DRUGS FOR RARE DISEASES TO BOOST MARKET 158
TABLE 125 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 159
TABLE 126 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 160
TABLE 127 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 160
TABLE 128 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 161
TABLE 129 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 161
TABLE 130 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 161
9.4 PERSONALIZED MEDICINE 162
9.4.1 RISING INCIDENCE OF CANCER AND INCREASING RESEARCH AND FUNDING TO DRIVE GROWTH 162
TABLE 131 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PERSONALIZED MEDICINE APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 163
TABLE 132 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PERSONALIZED MEDICINE APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 163
TABLE 133 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PERSONALIZED MEDICINE APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 164
TABLE 134 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PERSONALIZED MEDICINE APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 164
TABLE 135 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PERSONALIZED MEDICINE APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 165
TABLE 136 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PERSONALIZED MEDICINE APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 165
9.5 AGRICULTURE & ANIMAL RESEARCH 165
9.5.1 FAVORABLE FUNDING SCENARIO TO SUPPORT MARKET GROWTH 165
TABLE 137 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AGRICULTURE & ANIMAL RESEARCH APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 166
TABLE 138 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AGRICULTURE & ANIMAL RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 167
TABLE 139 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AGRICULTURE & ANIMAL RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 167
TABLE 140 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AGRICULTURE & ANIMAL RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 168
TABLE 141 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AGRICULTURE & ANIMAL RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 168
TABLE 142 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AGRICULTURE & ANIMAL RESEARCH APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 169
9.6 OTHER APPLICATIONS 169
TABLE 143 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 170
TABLE 144 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 170
TABLE 145 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 171
TABLE 146 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 171
TABLE 147 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 172
TABLE 148 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 172
10 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER 173
10.1 INTRODUCTION 174
TABLE 149 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2021–2028 (USD MILLION) 174
10.2 HOSPITALS & DIAGNOSTIC CENTERS 174
10.2.1 RISING FOCUS ON PERSONALIZED MEDICINE IN HOSPITALS TO DRIVE MARKET GROWTH 174
TABLE 150 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2021–2028 (USD MILLION) 176
TABLE 151 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2021–2028 (USD MILLION) 176
TABLE 152 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2021–2028 (USD MILLION) 177
TABLE 153 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2021–2028 (USD MILLION) 177
TABLE 154 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2021–2028 (USD MILLION) 178
TABLE 155 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2021–2028 (USD MILLION) 178
10.3 ACADEMIC & GOVERNMENT RESEARCH INSTITUTES 178
10.3.1 INCREASE IN RESEARCH INTENSITY TO DRIVE USAGE OF NUCLEIC ACID ISOLATION AND PURIFICATION SYSTEMS 178
TABLE 156 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION) 180
TABLE 157 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 180
TABLE 158 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 181
TABLE 159 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 181
TABLE 160 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 182
TABLE 161 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION) 182
10.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 182
10.4.1 INCREASING NUMBER OF RESEARCH PROJECTS IN GENOMICS AND RELATED AREAS TO DRIVE SEGMENT GROWTH 182
TABLE 162 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION) 183
TABLE 163 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 184
TABLE 164 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 184
TABLE 165 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 185
TABLE 166 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 185
TABLE 167 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION) 186
10.5 CONTRACT RESEARCH ORGANIZATIONS 186
10.5.1 CONTRACT RESEARCH ORGANIZATIONS TO REGISTER STEADY GROWTH DURING FORECAST PERIOD 186
TABLE 168 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2021–2028 (USD MILLION) 187
TABLE 169 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 187
TABLE 170 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 188
TABLE 171 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 188
TABLE 172 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 189
TABLE 173 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2021–2028 (USD MILLION) 189
10.6 OTHER END USERS 189
TABLE 174 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION) 190
TABLE 175 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 190
TABLE 176 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 191
TABLE 177 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 191
TABLE 178 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 192
TABLE 179 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION) 192
11 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION 193
11.1 INTRODUCTION 194
TABLE 180 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2021–2028 (USD MILLION) 194
11.2 NORTH AMERICA 194
FIGURE 32 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET SNAPSHOT 195
TABLE 181 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 196
TABLE 182 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021–2028 (USD MILLION) 196
TABLE 183 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 197
TABLE 184 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 197
TABLE 185 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 198
TABLE 186 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 198
TABLE 187 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2021–2028 (USD MILLION) 199
11.2.1 US 199
11.2.1.1 Government and private funding to support market growth 199
TABLE 188 US: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021–2028 (USD MILLION) 200
TABLE 189 US: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 200
TABLE 190 US: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 201
TABLE 191 US: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 201
TABLE 192 US: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 201
TABLE 193 US: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2021–2028 (USD MILLION) 202
11.2.2 CANADA 202
11.2.2.1 Growing investments in genomics to boost market demand 202
TABLE 194 CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021–2028 (USD MILLION) 203
TABLE 195 CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 203
TABLE 196 CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 204
TABLE 197 CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 204
TABLE 198 CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 204
TABLE 199 CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2021–2028 (USD MILLION) 205
11.2.3 NORTH AMERICA: RECESSION IMPACT 205
11.3 EUROPE 206
TABLE 200 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 206
TABLE 201 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021–2028 (USD MILLION) 207
TABLE 202 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 207
TABLE 203 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 208
TABLE 204 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 208
TABLE 205 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 208
TABLE 206 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2021–2028 (USD MILLION) 209
11.3.1 GERMANY 209
11.3.1.1 Germany to dominate market in Europe 209
TABLE 207 CANCER INCIDENCE IN GERMANY, BY TYPE, 2020 VS. 2027 210
TABLE 208 GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021–2028 (USD MILLION) 210
TABLE 209 GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 211
TABLE 210 GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 211
TABLE 211 GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 212
TABLE 212 GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 212
TABLE 213 GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2021–2028 (USD MILLION) 213
11.3.2 UK 213
11.3.2.1 Government support for research through investments, funds, and grants to support market growth 213
TABLE 214 UK: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021–2028 (USD MILLION) 214
TABLE 215 UK: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 214
TABLE 216 UK: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 215
TABLE 217 UK: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 215
TABLE 218 UK: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 215
TABLE 219 UK: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2021–2028 (USD MILLION) 216
11.3.3 FRANCE 216
11.3.3.1 High cancer burden to drive market growth 216
TABLE 220 FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021–2028 (USD MILLION) 217
TABLE 221 FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 218
TABLE 222 FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 218
TABLE 223 FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 219
TABLE 224 FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 219
TABLE 225 FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2021–2028 (USD MILLION) 220
11.3.4 ITALY 220
11.3.4.1 Government support to drive market growth in Italy 220
TABLE 226 ITALY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021–2028 (USD MILLION) 221
TABLE 227 ITALY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 221
TABLE 228 ITALY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 222
TABLE 229 ITALY: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 222
TABLE 230 ITALY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 222
TABLE 231 ITALY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2021–2028 (USD MILLION) 223
11.3.5 SPAIN 223
11.3.5.1 High adoption of advanced diagnostic technologies to drive market growth in Spain 223
TABLE 232 SPAIN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021–2028 (USD MILLION) 224
TABLE 233 SPAIN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 224
TABLE 234 SPAIN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 225
TABLE 235 SPAIN: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 225
TABLE 236 SPAIN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 225
TABLE 237 SPAIN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2021–2028 (USD MILLION) 226
11.3.6 REST OF EUROPE 226
TABLE 238 REST OF EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021–2028 (USD MILLION) 227
TABLE 239 REST OF EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 227
TABLE 240 REST OF EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 228
TABLE 241 REST OF EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 228
TABLE 242 REST OF EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 228
TABLE 243 REST OF EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2021–2028 (USD MILLION) 229
11.3.7 EUROPE: RECESSION IMPACT 229
11.4 ASIA PACIFIC 230
FIGURE 33 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET SNAPSHOT 231
TABLE 244 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 232
TABLE 245 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021–2028 (USD MILLION) 232
TABLE 246 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 233
TABLE 247 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 233
TABLE 248 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 234
TABLE 249 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 234
TABLE 250 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2021–2028 (USD MILLION) 235
11.4.1 CHINA 235
11.4.1.1 China to register highest growth in nucleic acid isolation and purification market in Asia Pacific region 235
TABLE 251 CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021–2028 (USD MILLION) 236
TABLE 252 CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 236
TABLE 253 CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 237
TABLE 254 CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 237
TABLE 255 CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 237
TABLE 256 CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2021–2028 (USD MILLION) 238
11.4.2 JAPAN 238
11.4.2.1 Growing number of conferences & workshops to drive market growth 238
TABLE 257 JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021–2028 (USD MILLION) 239
TABLE 258 JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 239
TABLE 259 JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 240
TABLE 260 JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 240
TABLE 261 JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 240
TABLE 262 JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2021–2028 (USD MILLION) 241
11.4.3 INDIA 241
11.4.3.1 Focused initiatives in pharmaceutical & biotechnology industries to drive market growth 241
TABLE 263 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021–2028 (USD MILLION) 242
TABLE 264 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 242
TABLE 265 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 243
TABLE 266 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 243
TABLE 267 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 243
TABLE 268 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2021–2028 (USD MILLION) 244
11.4.4 SOUTH KOREA 244
11.4.4.1 Support from governments to drive market in region 244
TABLE 269 SOUTH KOREA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021–2028 (USD MILLION) 245
TABLE 270 SOUTH KOREA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 245
TABLE 271 SOUTH KOREA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 246
TABLE 272 SOUTH KOREA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 246
TABLE 273 SOUTH KOREA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 246
TABLE 274 SOUTH KOREA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2021–2028 (USD MILLION) 247
11.4.5 REST OF ASIA PACIFIC (ROAPAC) 247
TABLE 275 REST OF ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021–2028 (USD MILLION) 248
TABLE 276 REST OF ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 249
TABLE 277 REST OF ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 249
TABLE 278 REST OF ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 250
TABLE 279 REST OF ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 250
TABLE 280 REST OF ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2021–2028 (USD MILLION) 251
11.4.6 ASIA PACIFIC: RECESSION IMPACT 251
11.5 LATIN AMERICA 251
TABLE 281 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 252
TABLE 282 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021–2028 (USD MILLION) 252
TABLE 283 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 253
TABLE 284 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 253
TABLE 285 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 254
TABLE 286 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 254
TABLE 287 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2021–2028 (USD MILLION) 255
11.5.1 BRAZIL 255
11.5.1.1 Brazil to dominate LATAM market 255
TABLE 288 BRAZIL: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021–2028 (USD MILLION) 256
TABLE 289 BRAZIL: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 256
TABLE 290 BRAZIL: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 257
TABLE 291 BRAZIL: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 257
TABLE 292 BRAZIL: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 257
TABLE 293 BRAZIL: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2021–2028 (USD MILLION) 258
11.5.2 MEXICO 258
11.5.2.1 Favorable trade agreements to support imports and improve access to NAIP instruments in Mexico 258
TABLE 294 MEXICO: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021–2028 (USD MILLION) 259
TABLE 295 MEXICO: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 259
TABLE 296 MEXICO: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 260
TABLE 297 MEXICO: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 260
TABLE 298 MEXICO: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 260
TABLE 299 MEXICO: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2021–2028 (USD MILLION) 261
11.5.3 REST OF LATIN AMERICA 261
TABLE 300 REST OF LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021–2028 (USD MILLION) 261
TABLE 301 REST OF LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 262
TABLE 302 REST OF LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 262
TABLE 303 REST OF LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 263
TABLE 304 REST OF LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 263
TABLE 305 REST OF LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2021–2028 (USD MILLION) 264
11.5.4 LATIN AMERICA: RECESSION IMPACT 264
11.6 MIDDLE EAST & AFRICA 265
TABLE 306 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2021–2028 (USD MILLION) 265
TABLE 307 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021–2028 (USD MILLION) 266
TABLE 308 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 266
TABLE 309 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 267
TABLE 310 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 267
TABLE 311 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 267
TABLE 312 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2021–2028 (USD MILLION) 268
11.6.1 MIDDLE EAST 268
11.6.1.1 Growing focus on molecular diagnostics and research to drive market 268
TABLE 313 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021–2028 (USD MILLION) 269
TABLE 314 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 269
TABLE 315 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 270
TABLE 316 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 270
TABLE 317 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 270
TABLE 318 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2021–2028 (USD MILLION) 271
11.6.2 AFRICA 271
11.6.2.1 Government support for research studies to fuel growth 271
TABLE 319 AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021–2028 (USD MILLION) 272
TABLE 320 AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 272
TABLE 321 AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 273
TABLE 322 AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 273
TABLE 323 AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 273
TABLE 324 AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2021–2028 (USD MILLION) 274
11.6.3 MIDDLE EAST & AFRICA: RECESSION IMPACT 274
12 COMPETITIVE LANDSCAPE 275
12.1 INTRODUCTION 275
12.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS 275
TABLE 325 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: STRATEGIES ADOPTED 275
12.3 REVENUE ANALYSIS 277
FIGURE 34 REVENUE ANALYSIS OF KEY PLAYERS (2018–2022) 277
12.4 MARKET SHARE ANALYSIS 278
FIGURE 35 MARKET SHARE ANALYSIS OF KEY PLAYERS (2022) 278
TABLE 326 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: DEGREE OF COMPETITION 279
12.5 COMPANY EVALUATION MATRIX 280
12.5.1 STARS 281
12.5.2 EMERGING LEADERS 281
12.5.3 PERVASIVE PLAYERS 281
12.5.4 PARTICIPANTS 281
FIGURE 36 COMPANY EVALUATION MATRIX, 2022 282
12.5.5 COMPANY FOOTPRINT ANALYSIS 283
12.5.5.1 Company footprint 283
TABLE 327 COMPANY FOOTPRINT ANALYSIS: KEY PLAYERS 283
12.5.5.2 Company product footprint 284
TABLE 328 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: PRODUCT FOOTPRINT ANALYSIS OF KEY PLAYERS 284
12.5.5.3 Company regional footprint 285
TABLE 329 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS 285
12.6 START-UP/SME EVALUATION MATRIX 287
12.6.1 PROGRESSIVE COMPANIES 287
12.6.2 RESPONSIVE COMPANIES 287
12.6.3 DYNAMIC COMPANIES 287
12.6.4 STARTING BLOCKS 287
FIGURE 37 START-UP/SME EVALUATION MATRIX, 2022 288
12.6.5 COMPETITIVE BENCHMARKING 289
TABLE 330 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: DETAILED LIST OF KEY START-UP/SME PLAYERS 289
TABLE 331 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: COMPETITIVE BENCHMARKING OF START-UP/SME PLAYERS 290
12.7 COMPETITIVE SCENARIO AND TRENDS 291
12.7.1 PRODUCT LAUNCHES 291
TABLE 332 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: PRODUCT LAUNCHES, JANUARY 2020–OCTOBER 2023 291
12.7.2 DEALS 292
TABLE 333 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: DEALS, JANUARY 2020 TO OCTOBER 2023 292
12.7.3 OTHER DEVELOPMENTS 293
TABLE 334 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: OTHER DEVELOPMENTS, JANUARY 2020 TO OCTOBER 2023 293
13 COMPANY PROFILES 294
(Business Overview, Products Offered, Recent Developments, MnM View Right to win, Strategic choices made, Weaknesses and competitive threats) *
13.1 MAJOR PLAYERS 294
13.1.1 THERMO FISHER SCIENTIFIC INC. 294
TABLE 335 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW 294
FIGURE 38 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2022) 295
13.1.2 QIAGEN 312
TABLE 336 QIAGEN: BUSINESS OVERVIEW 312
FIGURE 39 QIAGEN: COMPANY SNAPSHOT (2022) 313
13.1.3 F. HOFFMANN-LA ROCHE LTD. 322
TABLE 337 F. HOFFMANN-LA ROCHE LTD.: BUSINESS OVERVIEW 322
FIGURE 40 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2022) 323
13.1.4 MERCK KGAA 327
TABLE 338 MERCK KGAA: BUSINESS OVERVIEW 327
FIGURE 41 MERCK KGAA: COMPANY SNAPSHOT (2022) 328
13.1.5 PROMEGA CORPORATION 334
TABLE 339 PROMEGA CORPORATION: BUSINESS OVERVIEW 334
13.1.6 AGILENT TECHNOLOGIES, INC. 338
TABLE 340 AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW 338
FIGURE 42 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2022) 339
13.1.7 DANAHER 341
TABLE 341 DANAHER: BUSINESS OVERVIEW 341
FIGURE 43 DANAHER: COMPANY SNAPSHOT (2022) 342
13.1.8 BIO-RAD LABORATORIES, INC. 346
TABLE 342 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW 346
FIGURE 44 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2022) 347
13.1.9 ILLUMINA, INC. 349
TABLE 343 ILLUMINA, INC.: BUSINESS OVERVIEW 349
FIGURE 45 ILLUMINA, INC.: COMPANY SNAPSHOT (2022) 350
13.1.10 TAKARA BIO INC. 352
TABLE 344 TAKARA BIO INC.: BUSINESS OVERVIEW 352
FIGURE 46 TAKARA BIO INC.: COMPANY SNAPSHOT (2022) 353
13.1.11 NEW ENGLAND BIOLABS 357
TABLE 345 NEW ENGLAND BIOLABS: BUSINESS OVERVIEW 357
13.1.12 ABCAM PLC 361
TABLE 346 ABCAM PLC: BUSINESS OVERVIEW 361
FIGURE 47 ABCAM PLC: COMPANY SNAPSHOT (2022) 362
13.2 OTHER COMPANIES 364
13.2.1 KILPEST INDIA LIMITED 364
TABLE 347 KILPEST INDIA LIMITED: COMPANY OVERVIEW 364
13.2.2 APICAL SCIENTIFIC SDN. BHD. 365
TABLE 348 APICAL SCIENTIFIC SDN. BHD.: COMPANY OVERVIEW 365
13.2.3 ENDRESS+HAUSER GROUP SERVICES AG 366
TABLE 349 ENDRESS+HAUSER GROUP SERVICES AG: COMPANY OVERVIEW 366
13.2.4 GENAXXON BIOSCIENCE GMBH 367
TABLE 350 GENAXXON BIOSCIENCE GMBH: COMPANY OVERVIEW 367
13.2.5 LGC BIOSEARCH TECHNOLOGIES 368
TABLE 351 LGC BIOSEARCH TECHNOLOGIES: COMPANY OVERVIEW 368
13.2.6 ZYMO RESEARCH CORPORATION 369
TABLE 352 ZYMO RESEARCH CORPORATION: COMPANY OVERVIEW 369
13.2.7 NORGEN BIOTEK CORP. 372
TABLE 353 NORGEN BIOTEK CORP.: COMPANY OVERVIEW 372
13.2.8 OMEGA BIO-TEK, INC. 373
TABLE 354 OMEGA BIO-TEK, INC.: COMPANY OVERVIEW 373
13.2.9 FAVORGEN BIOTECH CORPORATION 375
TABLE 355 FAVORGEN BIOTECH CORPORATION: COMPANY OVERVIEW 375
13.2.10 TIANGEN BIOTECH(BEIJING)CO., LTD. 376
TABLE 356 TIANGEN BIOTECH(BEIJING)CO., LTD.: COMPANY OVERVIEW 376
13.2.11 AUTOGEN INC. 377
TABLE 357 AUTOGEN INC.: COMPANY OVERVIEW 377
13.2.12 PCR BIOSYSTEMS 379
TABLE 358 PCR BIOSYSTEMS: COMPANY OVERVIEW 379
13.2.13 BIOGENUIX 380
TABLE 359 BIOGENUIX: COMPANY OVERVIEW 380
*Details on Business Overview, Products Offered, Recent Developments, MnM View, Right to win, Strategic choices made, Weaknesses and competitive threats might not be captured in case of unlisted companies.
14 APPENDIX 381
14.1 DISCUSSION GUIDE 381
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 385
14.3 CUSTOMIZATION OPTIONS 387
14.4 RELATED REPORTS 387
14.5 AUTHOR DETAILS 388